Peri-operative Levosimendan in Patients Undergoing Cardiac Surgery: An Overview of the Evidence

Levosimendan, a calcium sensitiser, has recently emerged as a valuable agent in the peri-operative management of cardiac surgery patients. Levosimendan is a calcium-sensitising ionodilator. By binding to cardiac troponin C and reducing its calcium-binding co-efficient, it enhances myofilament respon...

Full description

Saved in:
Bibliographic Details
Published inHeart, lung & circulation Vol. 24; no. 7; pp. 667 - 672
Main Authors Shi, William Y., MBBS, Li, Sheila, BMed, Collins, Nicholas, FRACP, Cottee, David B., PhD, FANZCA, Bastian, Bruce C., FRACP, James, Allen N., FRACS, Mejia, Ross, FRACS
Format Journal Article
LanguageEnglish
Published Australia Elsevier B.V 01.07.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Levosimendan, a calcium sensitiser, has recently emerged as a valuable agent in the peri-operative management of cardiac surgery patients. Levosimendan is a calcium-sensitising ionodilator. By binding to cardiac troponin C and reducing its calcium-binding co-efficient, it enhances myofilament responsiveness to calcium and thus enhances myocardial contractility without increasing oxygen demand. Current evidence suggests that levosimendan enhances cardiac function after cardiopulmonary bypass in patients with both normal and reduced left ventricular function. In addition to being used as post-operative rescue therapy for low cardiac output syndrome, a pre-operative levosimendan infusion in high risk patients with poor cardiac function may reduce inotropic requirements, the need for mechanical support, the duration of intensive care admissions as well as post-operative mortality. Indeed, it is these higher-risk patients who may experience a greater degree of benefit. Larger, multicentre randomised trials in cardiac surgery will help to elucidate the full potential of this agent.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1443-9506
1444-2892
DOI:10.1016/j.hlc.2015.03.007